Key result
Mean plasma BNP levels were higher in patients with congestive heart failure compared to those without and correlated positively with LVEDP.
Why the study?
Does plasma BNP level correlate with the presence of congestive heart failure and left ventricular end diastolic pressure in patients undergoing hemodynamic monitoring?
Observational (n=50)
Does plasma BNP level correlate with the presence of congestive heart failure and left ventricular end diastolic pressure in patients undergoing hemodynamic monitoring?
Answers are grounded in this paper and cite their sources.
Plasma BNP is significantly elevated in patients with congestive heart failure and correlates positively with left ventricular end-diastolic pressure, supporting its utility in hemodynamic assessment.
Background and Objectives:B-type natriuretic peptide (BNP) is released from the cardiac ventricles in response to increased wall tension. Early diagnosis of congestive heart failure (CHF) and assessment of the left ventricular end diastolic pressure (LVEDP) are thought to be important in the diagnosis, treatment and follow up of patients with CHF. Subjects and Methods:Between March, 2002 and November, 2002, 50 patients, who were admitted for treatment and hemodynamic monitoring, were studied. For the BNP measurement, 3 to 5ml blood samples were collected into tubes containing EDTA. The BNP was measured with a fluorescence immunoassay kit (Triage, Biosite, San Diego, U.S.A.). Cardiac Catheterization was performed for the assessment of the LVEDP. Results: Of the 50 subjects, 34 with CHF had a mean BNP level of 483.1±77.8 pg/mL, whereas those without CHF had a level of 79.2±24.0 pg/mL. The difference between the groups was statistically significant (p=0.005). A significant positive correlation was seen between the BNP and the LVEDP (r=0.53, p=0.001). The correlation between the BNP and the left ventricular ejection fraction (LVEF) was not statistically significant (r=-0.226, p=0.198). Conclusion:The plasma BNP was significantly increased in CHF, and might reflect the LVEDP. Further study will be required to see whether the BNP is a useful parameter for the staging and treatment of CHF. (Korean Circulation J 2003;33 (8):695-700)
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2003) conducted an observational in Congestive Heart Failure (n=50). Congestive heart failure vs. No congestive heart failure was evaluated on Mean BNP level (p=0.005). Mean plasma BNP levels were higher in patients with congestive heart failure compared to those without and correlated positively with LVEDP.
Synapse has enriched 10 related papers. Consider them for comparative context: